Undervalued Large-Cap Healthcare Stocks on NYS June 2025

June 27, 2025

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
MRK Merck & Co 76.84 154.49 101.06 14498141 194482 4.11 11.2
BDX Becton Dickinson 172.59 314.97 82.50 4033055 49661 2.31 33.4
OGN Organon 9.22 14.97 62.34 8705781 2406 9.33 3.2
ARDT Ardent Health Partners 14.48 23.51 62.33 302981 2037 0.00 8.6
BAX Baxter Intl 30.50 48.89 60.30 3674265 15677 2.62 0.0
BIO Bio-Rad Laboratories 226.93 341.86 50.64 373720 6344 0.00 0.0
BIO.B Bio-Rad Laboratories 234.41 343.32 46.46 - 6553 0.00 0.0
ZBH Zimmer Biomet Holdings 92.17 133.78 45.14 3001428 18406 1.04 20.5
BLCO Bausch & Lomb 11.47 16.32 42.26 917110 4047 0.00 0.0
NVST Envista Holdings 18.27 22.38 22.52 2866423 3172 0.00 0.0
All data provided as at market close May 29, 2025.

Company Details

Merck & Co

MRK:NYS

Close Price

76.84

Our Valuation

154.49

% Difference

101.06

Market Cap ($M)

194482

P/E Ratio

11.2

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs.

Access the stockcalc valuation


Becton Dickinson

BDX:NYS

Close Price

172.59

Our Valuation

314.97

% Difference

82.50

Market Cap ($M)

49661

P/E Ratio

33.4

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder.

Access the stockcalc valuation


Organon

OGN:NYS

Close Price

9.22

Our Valuation

14.97

% Difference

62.34

Market Cap ($M)

2406

P/E Ratio

3.2

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan.

Access the stockcalc valuation


Ardent Health Partners

ARDT:NYS

Close Price

14.48

Our Valuation

23.51

% Difference

62.33

Market Cap ($M)

2037

P/E Ratio

8.6

Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Baxter Intl

BAX:NYS

Close Price

30.50

Our Valuation

48.89

% Difference

60.30

Market Cap ($M)

15677

P/E Ratio

0.0

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio.

Access the stockcalc valuation


Bio-Rad Laboratories

BIO:NYS

Close Price

226.93

Our Valuation

341.86

% Difference

50.64

Market Cap ($M)

6344

P/E Ratio

0.0

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories.

Access the stockcalc valuation


Bio-Rad Laboratories

BIO.B:NYS

Close Price

234.41

Our Valuation

343.32

% Difference

46.46

Market Cap ($M)

6553

P/E Ratio

0.0

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories.

Access the stockcalc valuation


Zimmer Biomet Holdings

ZBH:NYS

Close Price

92.17

Our Valuation

133.78

% Difference

45.14

Market Cap ($M)

18406

P/E Ratio

20.5

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products.

Access the stockcalc valuation


Bausch & Lomb

BLCO:NYS

Close Price

11.47

Our Valuation

16.32

% Difference

42.26

Market Cap ($M)

4047

P/E Ratio

0.0

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify.

Access the stockcalc valuation


Envista Holdings

NVST:NYS

Close Price

18.27

Our Valuation

22.38

% Difference

22.52

Market Cap ($M)

3172

P/E Ratio

0.0

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Merck & Co and Becton Dickinson are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-june-2025
Merck & Co $MRK and Becton Dickinson $BDX are the most undervalued Healthcare stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-june-2025
Merck & Co and Becton Dickinson are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-june-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.